chr2-171785291-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003705.5(SLC25A12):āc.2020G>Cā(p.Val674Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_003705.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A12 | NM_003705.5 | c.2020G>C | p.Val674Leu | missense_variant | 18/18 | ENST00000422440.7 | NP_003696.2 | |
SLC25A12 | XM_047446142.1 | c.1747G>C | p.Val583Leu | missense_variant | 16/16 | XP_047302098.1 | ||
SLC25A12 | NR_047549.2 | n.1934G>C | non_coding_transcript_exon_variant | 17/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A12 | ENST00000422440.7 | c.2020G>C | p.Val674Leu | missense_variant | 18/18 | 1 | NM_003705.5 | ENSP00000388658.2 | ||
SLC25A12 | ENST00000263812.8 | n.*1640G>C | non_coding_transcript_exon_variant | 17/17 | 2 | ENSP00000263812.4 | ||||
SLC25A12 | ENST00000472070.1 | n.1430G>C | non_coding_transcript_exon_variant | 3/3 | 2 | |||||
SLC25A12 | ENST00000263812.8 | n.*1640G>C | 3_prime_UTR_variant | 17/17 | 2 | ENSP00000263812.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251446Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135898
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727234
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 05, 2019 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SLC25A12-related conditions. ClinVar contains an entry for this variant (Variation ID: 452173). This variant is present in population databases (rs761108884, ExAC 0.01%). This sequence change replaces valine with leucine at codon 674 of the SLC25A12 protein (p.Val674Leu). The valine residue is weakly conserved and there is a small physicochemical difference between valine and leucine. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 02, 2017 | The V674L variant in the SLC25A12 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The V674L variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The V674L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved, and in silico analysis predicts this variant likely does not alter the protein structure/function. We interpret V674L as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at